a b s t r a c t
Protein palmitoylation is a post-translational modification that contributes to determining protein localization and function. Palmitoylation has been described in trypanosomatid protozoa, but no zDHHC palmitoyl transferase has been identified in Trypanosoma cruzi, the etiological agent of Chagas disease in Latin America. In this study we identify and show the subcellular localization of TcHIP (Tc00.1047053508199.50), a putative T. cruzi zDHHC palmitoyl transferase. Analysis of the deduced protein sequence indicates that it contains ankyrin repeats (Ank and Ank2) and the zDHHC conserved domain, typical of zDHHC palmitoyl transferases. A TcHIP polyclonal antiserum obtained from mice immunized with the purified recombinant protein was used to study the presence and subcellular localization of the native enzyme. In western blots this antiserum recognized a protein of about 95 kDa, consistent with the predicted molecular mass of TcHIP (95.4 kDa), in whole extracts of T. cruzi epimastigotes, metacyclic trypomastigotes and intracellular amastigotes. Immunolocalization by confocal microscopy showed TcHIP labeling at the Golgi complex, co-localizing with the T. cruzi Golgi marker TcRab7-GFP. Transfectant T. cruzi epimastigotes containing a construct encoding TcHIP fused to proteins A and C (TcHIP/AC) were obtained. In western blotting experiments, the TcHIP polyclonal antiserum recognized both native and TcHIP/AC proteins in extracts of the transfectants. Confocal microscopy showed colocalization of native TcHIP with TcHIP/AC. These findings demonstrate the presence of a putative zDHHC
Introduction
Palmitoylation is a type of acylation that involves addition of palmitic acid to a protein. This modification can regulate the protein's localization, function, membrane anchoring, lipid raft segmentation and trafficking (Corvi et al., 2011) . It is catalyzed by two different families of palmitoyl transferases. One group present a cysteine-rich domain, containing a zinc molecule and the ''asphis-his-cys'' motif (zDHHC), which is responsible for their function (Putilina et al., 1999) . The other enzyme type is the membranebound O-acyltransferase (MBOAT), which is involved in palmitoylation of various signaling proteins (Corvi et al., 2011) .
The human Huntingtin Interacting Protein 14 (HIP-14) is a zDHHC palmitoyl transferase that is associated with the Golgi complex (Singaraja et al., 2002) and regulates the trafficking and function of the neuronal protein huntingtin (Yanai et al., 2006) . The enzyme PfAnkDHHC palmitoyl transferase (containing ankyrin and zDHHC domains) is found in the protozoan Plasmodium falciparum and, like its human homologue HIP-14, is also found at the Golgi complex (Seydel et al., 2005) . Although protein palmitoylation has been described in several apicomplexan protozoa, such as Eimeria spp. (Donald and Liberator, 2002) , Toxoplasma spp. (Gilk et al., 2009 ) and P. falciparum (Rees Channer et al., 2006; Russo et al., 2009) , little is known about the presence and function of palmitoyl transferases in trypanosomatid protozoa.
Myristoylation is an acyl modification that increases the total hydrophobicity of the protein. Some proteins also require palmitoylation at their N-terminus after myristoylation, for stable membrane attachment and/or protein translocation to rafts/caveolae or intracellular liquid-ordered domains (Levental et al., 2010; McCabe and Berthiaume, 1999; McCabe and Berthiaume, 2001; Shahinian and Silvius, 1995; Webb et al., 2000) . No such dually acylated protein have been reported in the trypanosomatids Trypanosoma brucei, Trypanosoma cruzi or Leishmania major (Emmer et al., 2011; Godsel and Engman, 1999; Tull et al., 2004; Tyler et al., 2009 ). In T. brucei, the etiological agent of African trypanosomiasis, a palmitoyl transferase containing the zDHHC domain is required for sorting of calflagin (a Ca 2+ -binding protein) to the flagellar membrane (Emmer et al., 2009) . The localization of calflagins depends on their acylation status: calflagins that are only myristoylated are targeted to the cell body membrane; if after myristoylation they are palmitoylated at their N-terminus, they are directed to the flagellar membrane (Emmer et al., 2011) . The flagellar calcium-binding protein (FCaBP) of T. cruzi is another dually acylated protein (Godsel and Engman, 1999) , dual acylation being necessary for protein targeting to both flagellum and lipid rafts at the flagellar membrane of this parasite (Tyler et al., 2009 ). Dual acylation is also essential for the export of phosphatidylinositol-phospholipase C (PI-PLC) to the outer surface of T. cruzi intracellular amastigotes (Furuya et al., 2000; Martins et al., 2010) . Furthermore, the small myristoylated and palmitoylated SMP-1 protein is targeted to the flagellar membrane in Leishmania major (Tull et al., 2004) . These various data indicate that protein acylation plays an important role in targeting proteins to the flagellar and other cell membranes in trypanosomatids.
No zDHHC palmitoyl transferase has previously been described in T. cruzi, the etiological agent of Chagas disease in Latin America. The aim of this work was to identify a palmitoyl transferase in this parasite and assess its expression level and subcellular localization. We report the presence of a zDHHC palmitoyl transferase (TcHIP), containing ankyrin and zDHHC domains, in various developmental forms of T. cruzi, associated with the Golgi complex.
Material and methods

Reagents
Alkaline phosphatase-conjugated goat anti-mouse or goat anti-rabbit antibodies, mouse anti-histidine antibody, rabbit antiprotein A antibody, neomycin (G418), bromophenol blue, 
Parasites
Cultured epimastigotes of T. cruzi clone Dm28c (Contreras et al., 1988) were maintained by weekly passages at 28°C in liver infusion tryptose (LIT) medium (Camargo, 1964) supplemented with 10% heat inactivated FCS. For TcHIP cloning, DNA was extracted from three-day-old cultured epimastigotes by a phenol-chloroform method (Sambrook et al., 1989) .
In vitro-derived T. cruzi metacyclic trypomastigotes were obtained by incubating epimastigotes in TAU3AAG medium, according to a previously described metacyclogenesis (epimastigote-to-trypomastigote differentiation) protocol (Contreras et al., 1985) . After 72 h of cultivation in this medium, about 80% of the cells in the supernatant were in the trypomastigote form.
To obtain T. cruzi intracellular amastigotes, 5 Â 10 4 Vero cells (ATCC CCL-81) were seeded on circular glass coverslips and maintained at 37°C in DMEM supplemented with 5% FCS in a humidified 5% CO 2 atmosphere. After 24 h, the cells were infected with in vitro-derived metacyclic trypomastigotes (ratio: 10 parasites per host cell). After 4 h of interaction, the cell monolayers were washed with PBS to remove non-adherent parasites and then further incubated in the same conditions. Intracellular amastigotes were obtained three days post-infection. Intracellular amastigotes were visualized by confocal microscopy of infected Vero cells.
In silico analysis
The TritrypDB database was searched for a T. cruzi gene encoding an aminoacid sequence of a putative palmitoyl transferase and a gene with the i.d. Tc00.1047053508199.50 (TcHIP) was identified. The deduced aminoacid sequence of TcHIP was aligned with the Protein Blast algorithm (Blastp-NCBI, Bethesda, MD, USA). For domain analysis pFAM software (Sanger Institute, Cambridge, UK) was used. The ClustalW algorithm (EMBL, Heildeberg, Germany) was used for multiple aminoacid sequence alignments by using the randomly selected sequences of putative zDHHC palmitoyl transferases in several organisms, with the NCBI accession numbers: XP_80987.1 (T. cruzi), XP_827117.1 (T. brucei), XP_001561741.1 (Leishmania braziliensis), XP_888588.1 (L. major), NP_648824.1 (Drosophila melanogaster), NP_056151.2 (Homo sapiens), NP_766142.2 (Mus musculus), NP_010550.1 (Saccharomyces cerevisae) and XP_001351109.1 (Plasmodium falciparum).
Cloning, expression and purification of TcHIP
A 900 bp segment at the 5 0 end of the gene that encodes TcHIP (2610 bp) was used to design primers (Forward: 5 0 ATGCAGGTG-TTTGGCGCTCGGATG-3 0 and Reverse: 5 0 TCAGCAACAACGAACGCA-GA-3 0 ) with recombination sites (attBs) to enable entry into the Gateway cloning platform (Life Technologies-Invitrogen, USA). Escherichia coli strain BL21 (DE3) pLys was used for recombinant protein production (TcHIP+pDEST17 vector expressing histidine tag), performed by adding 1 mM IPTG to the cell culture. Production of the recombinant protein was analyzed by SDS-PAGE (Laemmli, 1970) stained with Coomassie Brilliant Blue R-250. The insoluble fraction of the recombinant protein was purified from the polyacrylamide gel by elution, and was analyzed by SDS-PAGE.
To confirm the presence of histidine-tagged recombinant protein, western blot (Towbin et al., 1979) was performed by using an anti-histidine antibody diluted to 1:3000 in blocking buffer (PBS containing 0.05% Tween and 5% non-fat dry milk). For competitive binding analysis, 50 lg of purified recombinant protein was incubated for one hour with the anti-histidine antibody (1:3000). The resulting immune-complex was then incubated with a nitrocellulose membrane containing the purified recombinant protein.
Protein extraction
Three-day-old culture epimastigotes (3 Â 10 7 parasites ml À1 ) and in vitro-derived metacyclic trypomastigotes (3.5 Â 10 8 parasites ml À1) were resuspended in non-denaturing buffer-A (20 mM Tris-HCl pH 8.0; 300 mM NaCl; 1 mM PMSF). Isolated intracellular amastigotes (10 9 parasites ml À1 ) and uninfected Vero cells (3 Â 10 6 cells ml À1 ) were resuspended in denaturing buffer-B (40 mM Tris-HCl pH 6.8; 1% SDS; 360 mM b-mercaptoethanol; 6% glycerol; 0.005% bromophenol blue). Parasites and Vero cells were lysed by eight vortex-ice bath cycles and the cell homogenates were then centrifuged at 9000g for 10 min. The protein content of the extract was determined by a micro-BCA (bicinchoninic acid) assay (Smith et al., 1985) . All protein extracts were ressuspended in denaturating buffer B and 30 lg aliquots of protein were boiled for 5 min at 100°C and applied to polyacrylamide gels.
Generation of T. cruzi transfectants
To generate transfectant epimastigotes expressing TcHIP fused to proteins A and C (TcHIP/AC) at its amino-terminus, primers were designed (Forward: 5 0 GGGGACAAGTTTGTACAAAAAAGCAGGCTT-CATGTCATCATCACCGTCATTGTTA-3 0 and Reverse: 5 0 GGGGACCAC-TTTGTACAAGAAAGCTGGGTCCACGGCGTTCATCTTTCACCT-3 0 ) to amplify the TcHIP gene (2610 bp) without the stop codon and give a fragment suitable for use with the Gateway cloning platform. PCR using minipreparations of plasmid vector containing the TcHIP gene fused to pTcGWPTP as a template was performed to confirm the appropriate insertion. The pTcGWPTP vector contains sequences encoding proteins A and C and is a modification of the pTcGWGFP vector, previously described by Batista et al. (2010) . For annealing, the Forward primer corresponding to the part of pTcGWPTP vector encoding the N-terminus (5 0 -GGGCATGCA-TGGCAGGCCTTGCGCAC-3 0 ) and the Reverse primer of the TcHIP gene were used. TcHIP/AC epimastigotes were transfected, selected and maintained as previously described (Batista et al., 2010) . Western blot with an anti-protein-A antibody diluted to 1:20,000 was used to confirm the presence of protein-A in protein extracts (60 lg) of TcHIP/AC epimastigotes.
TcRab7 is a Golgi marker in T. cruzi (Araripe et al., 2004) . Thus, a plasmid vector encoding TcRab7 fused to GFP (kindly provided by Michel Batista, Instituto Carlos Chagas/FIOCRUZ-Paraná) was used to obtain TcRab7-GFP transfectant T. cruzi epimastigotes, as previously described (Batista et al., 2010) .
Polyclonal antiserum and Western blot
Three male albino Swiss mice (30-45 days) were intraperitoneally immunized with 50 lg of purified TcHIP recombinant protein plus complete Freund's adjuvant, followed by four doses of 20 lg TcHIP+Alu-Gel-S, one every two weeks. A polyclonal anti-TcHIP serum was then obtained by cardiac puncture. This experiment was conducted in strict accordance with the recommendations of the Guide for Animal Use of the FIOCRUZ Committee on Animal Experimentation (protocol number P-0434/07).
This polyclonal antiserum (diluted at 1:200 in blocking buffer) was used in western blotting experiments to study the expression of the native TcHIP in protein extracts from T. cruzi epimastigotes, metacyclic in vitro-derived trypomastigotes and intracellular amastigotes, as well as in Vero cells. ImageJ 1.45s software (National Institute of Mental Health-NIMH, Bethesda, Maryland, USA) was used for densitometry analysis to evaluate the protein expression levels. Values for TcHIP expression in the different T. cruzi developmental stages were normalized to the signal given by a murine anti-TcActin serum (diluted at 1:200 in blocking buffer). For competitive binding analysis, 50 lg of purified recombinant protein was incubated for one hour with the anti-TcHIP serum (1:200). The resulting immune-complex was then incubated with a nitrocellulose membrane containing an epimastigote protein extract.
Fluorescence microscopy assays
T. cruzi epimastigotes, in vitro-derived metacyclic trypomastigotes and intracellular amastigotes were washed twice in PBS, fixed for 10 min with 4% paraformaldehyde and incubated for one hour at 25°C with the pre-immune or the polyclonal TcHIP antisera diluted at 1:150 in incubation buffer (PBS pH 7.4 containing 1% BSA). After three washes in PBS, the samples were incubated in the same conditions with a secondary goat anti-mouse antibody coupled to AlexaFluor 488 or 594 diluted at 1:600 in incubation buffer. The samples were washed three times with PBS, incubated for 5 min with 1.3 nM DNA marker Hoechst 33342, and studied under a Leica SP5 confocal laser microscope (Leica Microsystems, Wetzlar, Germany).
For competitive binding assays, 50 lg of purified TcHIP recombinant protein was incubated for 1 h with the TcHIP polyclonal antiserum diluted in incubation buffer to 1:150. The resulting immune-complex was then incubated with T. cruzi epimastigotes and the experiment proceeded as described above.
To study co-localization of native TcHIP in transfectant epimastigotes expressing TcHIP/AC, three-day-old transfectant epimastigotes were washed twice in PBS, fixed for 30 min with 4% paraformaldehyde and incubated for 1 h at 37°C with the TcHIP polyclonal antiserum (1:150) or with the protein-A antibody (1:40,000). The samples were washed three times in PBS, and incubated in the same conditions with a secondary goat anti-mouse antibody coupled to AlexaFluor 488 (1:600) and a goat anti-rabbit antibody coupled to AlexaFluor 594 (1:600). A negative control was performed by incubating the protein-A antibody with wild-type epimastigotes. The experiment then proceeded as described above.
To study co-localization of native TcHIP in transfectant epimastigotes expressing TcRab7/GFP, three-day-old cultured transfectant epimastigotes were washed twice in PBS, fixed for 30 min with 4% paraformaldehyde and incubated for one hour at 37°C with the TcHIP polyclonal antiserum (1:150). The samples were washed three times in PBS, incubated in the same conditions with a secondary goat anti-mouse antibody coupled to AlexaFluor 594 (1:600). The experiment then proceeded as described above.
Results
Identification of the TcHIP gene
A gene with i.d. Tc00.1047053508199.50 was identified in the TritrypDB database. This gene is 2610 bp long, maps between nucleotide positions 166,176 and 168,785 of the T. cruzi chromosome 8 and encodes a putative Huntingtin Interacting Protein (HIP) of 869 amino acids (95.4 kDa). Amino acid alignments revealed that TcHIP is conserved in trypanosomatids (Table 1) , with maximum identity of between 35% (with the sequence in L. major) to 40% (with the sequence in T. congolense). Furthermore, three TcHIP i.ds. were observed in T. cruzi and two in T. brucei, related to different haplotypes and strains of these parasites (Table 1) .
TcHIP is an ankyrin and putative zDHHC palmitoyl transferase
Analysis of TcHIP gene revealed that the encoded protein contains ankyrin repeats (Ank and Ank-2) and the conserved zDHHC domain (Fig. 1A) . As expected, the conserved motif ''asp-his-hiscys'' (zDHHC domain) was found between the amino acids 400-700 in all organisms (Fig. 1B) , with, in a few cases the second histidine (H) replaced by tyrosine (Y; in S. cerevisae, T. cruzi, T. brucei) or phenylalanine (F; in Leishmania). Some conserved amino acids were also found in the region near the zDHHC motif, notably glycine and asparagine.
Cloning of TcHIP in E. coli and purification of the recombinant protein
A fragment of approximately 900 bp encoding TcHIP was amplified by PCR from genomic DNA of T. cruzi strain Dm28c and inserted into the vectors pDONR 221 and pDEST17. Both constructs were confirmed by PCR and nucleotide sequencing. Expression of the insoluble recombinant his-tagged TcHIP protein from pDEST17 in E. coli was evaluated by SDS-PAGE ( Fig. 2A ) and western blotting with anti-histidine antibodies (Fig. 2B) . Total extracts of bacteria without the expression vector were used as negative controls (see Fig. 2A , lane 1 for the electrophoretic banding pattern) and gave no signal with the anti-histidine antibody (Fig. 2B, lane 1) . Extracts of the uninduced bacteria with the expression vector showed basal expression of a protein with about 40 kDa (Fig. 2A, lane 2) , recognized by the anti-histidine antibody (Fig. 2B, lane 2) . After 3 h of induction with 1 mM IPTG, the protein banding at about 40 kDa was much more abundant ( Fig. 2A, lane 3) . This electrophoretic profile was consistent with the expected molecular mass of the TcHIP recombinant protein (33 kDa for the TcHIP sequence plus 6 kDa for the histidine tag) and the protein was recognized by the anti-histidine antibody (Fig. 2B, lane 3) .
This 40 kDa polypeptide was purified by elution, analyzed by SDS-PAGE (Fig. 2A, lanes 4, 5 and 6 ) and the presence of the TcHIP recombinant protein was confirmed by western blotting with an anti-histidine antibody (Fig. 2B, lanes 4, 5 and 6) . The bands at lower molecular mass (present in the elutions) were different from those for induced bacterial extracts, and were recognized by the anti-histidine antibody. A competitive western blot assay was performed to confirm the specificity of the anti-histidine antibody for the purified recombinant TcHIP protein: pre-incubation of purified recombinant TcHIP with the anti-histidine antibody decreased its binding to the recombinant protein bound to the nitrocellulose membrane (data not shown).
TcHIP expression in different T. cruzi developmental stages
The murine polyclonal anti-TcHIP serum recognized a protein of about 95 kDa in T. cruzi extracts (Fig. 2C, lanes 1, 2 and 3) , consistent with the expected molecular mass of the native TcHIP (95.4 kDa). Normalizing the signals to that obtained with a murine polyclonal serum against TcActin (42 kDa) as a reference, indicated that TcHIP was similarly abundant in various T. cruzi developmental stages (Fig. 2C, 2D ). However, native TcHIP expression was higher in five-day-old epimastigotes (Supplementary material S1). As expected, no reaction was observed after incubation of epimastigote protein extracts with the pre-immune antiserum (Fig. 2C, lane 4) . Although a cross-reaction with Vero cell extracts was observed, the reacting protein band was slightly lower (Fig. 2C, lane 5) . Pre-incubation of the TcHIP antiserum with purified recombinant TcHIP completely abolished recognition of native TcHIP in protein extracts of T. cruzi epimastigotes (data not shown), confirming the specificity of the TcHIP antiserum.
Generation of TcHIP/AC transfectant epimastigotes
The TcHIP gene was inserted into a pTcGWPTP vector such that proteins A/C would be fused to the N-terminus of the encoded protein. Analysis by PCR confirmed that the amplicon had the expected size (2607 bp of TcHIP gene, plus about 400 bp of the PTP gene, data not shown). Two other fragments were also amplified, corresponding to the plasmid DNA used as a template for the amplification. Epimastigotes transfected with the TcHIP/AC construct were selected, and western blot analysis with anti-protein-A antibody confirmed the presence of a protein-A fusion, at about 115 kDa, in the protein extracts (Fig. 2E) . The TcHIP antiserum recognized two proteins at about 95 kDa and 115 kDa, in these extracts, corresponding to the native TcHIP and TcHIP/AC, respectively. Incubation of the anti-protein-A tag antibody with wild-type epimastigote protein extract abolished its specific binding in western blots; the only band observed was the 42 kDa protein that corresponds to the TcActin normalizer. Densitometry analysis was used to compare the expression levels of native TcHIP and TcHIP/ AC proteins. The TcHIP/AC band intensity was in all cases weaker, regardless of whether antibodies to TcHIP or to the protein A tag were used; this indicates that native TcHIP was highly expressed (Fig. 2F ).
Immunolocalization of TcHIP
Immunolocalization of TcHIP in T. cruzi parasites by confocal microscopy revealed a strong positive spot at the anterior end of the cells, close to the kinetoplast and the flagellar pocket of epimastigotes and intracellular amastigotes (Fig. 3B, C, J, K) . In many cases there was labeling lateral to the kinetoplast (Fig. 3C, K) . In in vitro-derived metacyclic trypomastigotes, this single positive spot was located between the kinetoplast and the nucleus (Fig. 3F, G) . This localization is compatible with the single Golgi complex of trypanosomatids, which is found close to kinetoplast, in the flagellar pocket region.
Competitive immunofluorescence assays were used to confirm the specificity of the TcHIP antiserum. As expected, pre-incubation of purified recombinant TcHIP with the TcHIP antiserum completely abolished the labeling described above (Fig. 3M) . Epimastigote forms were also incubated with pre-immune serum and this resulted in weak diffuse labeling throughout the cytoplasm (Fig. 3N) . These results confirmed those of competitive and preimmune western blot assays, and demonstrate the specificity of the antibody.
Incubation of TcHIP/AC transfectant epimastigotes with antiprotein-A tag antibodies resulted in labeling in part of the population, and in all cases this labeling was close to the kinetoplast and flagellar pocket (Supplementary material S2) . When the antiprotein-A tag antibody was incubated with wild-type epimastigotes, no cytoplasmic labeling was detected (Fig. 3P, negative control) . Incubation of TcHIP/AC epimastigotes with both antiprotein-A tag and TcHIP antisera resulted in co-localization of the two labels (Fig. 3O) , further confirming the specificity of the TcHIP antiserum.
Finally, transfected T. cruzi epimastigotes expressing the Golgi marker TcRab7-GFP were probed with the TcHIP polyclonal antiserum: the two labels were superimposed, confirming that the TcHIP was present in the Golgi apparatus (Fig. 3Q , R, T).
Discussion
Palmitoylation is an important post-translational protein modification, and can alter protein localization and function. Study of palmitoyl transferases, enzymes that catalyze this modification, should help in understanding the role of such modifications in the cell biology of parasites. Indeed, protein acylation has already been described in parasitic protozoa (Corvi et al., 2011) , which consequently incorporate lipids, including palmitic acid, from their hosts into their own protein (Coppens et al., 2006; Quittnat et al., 2004) .
In silico searches allowed us to find a putative zDHHC palmitoyl transferase (TcHIP) encoded in the genome of the trypanosomatid protozoan T. cruzi. Aminoacid alignments showed that TcHIP is conserved in trypanosomatids, suggesting that it may have similar functions in all these parasites. The TcHIP protein has ankyrin repeats (Ank and Ank-2) and the zDHHC domain. Ankyrin repeats consist of repetitive stretches of 33 residues of glutamine and lysine, as also described in signaling proteins. They mediate protein-protein interactions and are among the most common structural motifs in known proteins (Mosavi et al., 2004) . Palmitoyl transferases also have cysteine-rich domains containing the ''asphis-his-cys'' (DHHC) motif involved in adding palmitic acid to proteins usually anchored to Golgi complex membranes (Putilina et al., 1999) . Most zDHHC palmitoyl tranferases also present ankyrin and plexin repeats, and these may be responsible for either substrate specificity or interaction with a possible regulator (Corvi et al., 2011) .
Multiple aminoacid alignments showed substantial conservation of some residues in the zDHHC palmitoyl transferases in several eukaryotic organisms including T. cruzi; some of these conserved aminoacids are typical of the ankyrin repeats, such as alanine and lysine (Mosavi et al., 2004) , and some are typical of the zDHHC domain, such as aspartate, histidine and cysteine, which correspond to the ''asp-his-his-cys'' motif (Putilina et al., 1999) . Only a few substitutions of the second histidine were observed, replaced by tyrosine (DHYC) in S. cerevisae, T. cruzi, T. brucei and phenylalanine in Leishmania. Interestingly, it has been shown that the replacement of the second histidine with tyrosine in the zDHHC motif in S. cerevisae does not reduce the enzyme activity, as demonstrated by in vivo and in vitro experiments; the S. cerevisae zDHHC palmitoyl transferase (Akr1p) containing the DHYC motif is required for casein kinase Yck2p palmitoylation (Roth et al., 2002) . Further work is required to assess the significance of these sequence variants for T. cruzi TcHIP expression and whether they are required for enzyme function. Multiple alignments also revealed both similar and somewhat similar aminoacids at numerous positions, contributing to the conservation of these domains in the various different organisms.zDHHC palmitoyl transferases are usually found at the endoplasmic reticulum, and Golgi and plasma membranes (Ohno et al., 2006) . A recent report suggested that the Golgi complex may act as a hub for palmitoylation of peripheral proteins, and this may be the case for various substrates of zDHHC palmitoyl transferases (Michaelson et al., 2002 ). An example is huntingtin in human cells that is palmitoylated by the Golgi zDHHC palmitoyl transferase HIP-14 (homologue to TcHIP), which regulates its trafficking and function (Singaraja et al., 2002; Yanai et al., 2006) . Furthermore, HIP14 co-localizes with coated vesicle markers, such as c-adaptin (Golgi Adaptor Complex 1) and clathrin (Singaraja et al., 2002) . Accordingly, it has been shown that PfAnkDHHC of P. falciparum, a zDHHC palmitoyl transferase orthologue of HIP-14 and TcHIP, is localized in the Golgi complex (Seydel et al., 2005) .
To study the expression of native TcHIP, we obtained a portion of the gene, fused it to a sequence encoding a histidine tag, and expressed it in a prokaryotic vector. A 40 kDa polypeptide was purified by elution and confirmed to be recombinant TcHIP by western blotting with an anti-histidine antibody. Western blotting of the eluted protein gave additional protein bands with lower molecular mass recognized by anti-histidine antibodies, which were probably TcHIP degradation or proteolysis products.
The purified polypeptide was used to immunize mice to obtain an anti-TcHIP polyclonal serum. Western blotting experiments showed that the antiserum recognized a major polypeptide of about 95 kDa, consistent with the expected molecular mass of the predicted TcHIP protein, in different developmental stages of T. cruzi; this protein was expressed at similar levels in the different stages. However, the intensity of the TcHIP protein band was higher for extracts of five day-old epimastigotes than three day-old epimastigotes (Supplementary material S1). This may indicate differential expression of the protein during culture growth. Curiously, transcriptomic data for TcHIP for the T. cruzi life cycle available from the TritrypDB database (data not shown) are not consistent with our expression data. This may be related to posttranscriptional regulation processes, common in trypanosomatids and which depend on extracellular signals (De Gaudenzi et al., 2011; Araújo and Teixeira, 2011) .
There was cross-reaction of the TcActin and TcHIP antisera with Vero cells extracts, but the protein bands recognized were of slightly lower molecular mass. This was presumably due to recognition of orthologous proteins with lower molecular mass, or a technical artifact.
We report TcHIP expression in different developmental stages of T. cruzi. Protein palmitoylation may be a crucial modification of membrane proteins involved in parasite-host cell interaction and invasion, modulating their functions. A recent report showed that 2-bromopalmitate (2BP), a palmitoylation inhibitor, alters gliding, host cell invasion and parasite morphology in the Apicomplexa protozoan Toxoplasma gondii (Alonso et al., 2012) . Thus, it would be interesting to explore whether inhibition of protein palmitoylation in T. cruzi amastigotes and trypomastigotes (mammalian forms) could be exploited as a metabolic target.
To confirm TcHIP expression and localization in T. cruzi epimastigotes, transfectant epimastigotes containing TcHIP fused to proteins A/C (TcHIP/AC) were generated. Western blot confirmed the presence of proteins A/C in the protein extract of TcHIP/AC epimastigotes. However, TcHIP/AC labeling was weaker than that of native TcHIP with both TcHIP antiserum and protein-A antibody, possibly due to expression of the fused protein in only part of the population (Supplementary material S2) . Indeed, when 30 lg of TcHIP/AC epimastigote protein extract was used, intensity of the TcHIP/AC protein band was weak (data not shown). Therefore, we decided to use 60 lg of protein extract from TcHIP/AC transfectant epimastigotes in experiments.
Confocal microscopy and the polyclonal TcHIP antiserum were used for immunolocalization of the native TcHIP. In epimastigotes, in vitro-derived metacyclic trypomastigotes and intracellular amastigotes, labeling was found as a single spot close to the kinetoplast and flagellar pocket. Competitive immunofluorescence and co-localization of TcHIP in epimastigotes expressing TcHIP/AC confirmed the specificity of the antiserum for TcHIP. The cellular localization was compatible with the Golgi complex of trypanosomatids, which is always close to the proximal region of the flagellar pocket (near the kinetoplast), usually with the trans-side facing the flagellar pocket (Girard-Dias et al., 2012; Soares and De Souza, 1988) . TcRab7 is a Golgi marker in T. cruzi (Araripe et al., 2004; Batista et al., 2010) , and we found it to co-localize with TcHIP, confirming that TcHIP localizes at the Golgi complex. This result is in accordance with our in silico analysis, which demonstrated the presence of the ankyrin repeats and a zDHHC domain in TcHIP, a pattern typical of other homologous palmitoyl transferases (HIP-14, PfAnkDHHC) that are associated with the Golgi complex in other eukaryotic cell types (Singaraja et al., 2002; Seydel et al., 2005) .
A palmitoyl proteome of T. brucei has recently been described by LC/MS-MS and diverse types of palmitoylated proteins were found, including proteases, antigens/surface proteins, membrane transporters and vesicle/trafficking proteins. One of these proteins is a cysteine protease precursor (Emmer et al., 2011) . T. cruzi epimastigotes contain a major cysteine protease (cruzipain), which is a mannose-rich glycoprotein that accumulates in reservosomes Soares et al., 1992) . Protein alignments showed that cruzipain (NCBI accession number: XM_813485.1) shares 59% identity with the T. brucei cysteine protease precursor (NCBI accession number: P14658). Reservosomes are the end compartment of the endocytic pathway, where ingested proteins accumulate . T. cruzi lacks a mannose-6-phosphate receptor (Cazzulo et al., 1990) , and it is still not known how cruzipain is routed from the Golgi complex to the reservosomes. Our study indicates that TcHIP is a putative palmitoyl transferase, associated with the Golgi complex of T. cruzi. Palmitic acid is attached to cysteine residues usually through a thioester bond (Linder and Deschenes, 2003) . Cruzipain has an N-teminal cysteine (C) residue, and several other C residues scattered throughout the aminoacid sequence. Thus, it is tempting to speculate that palmitoylation may direct cruzipain (and/or other glycoproteins) from the Golgi to reservosomes.
Endosomal integral membrane proteins involved in vesicular trafficking, such as l-adaptin (Golgi Adaptor Complex 1), Rab1, Rab7 and TcHIP, have been found in the subcellular proteomes of a purified reservosomal fraction , indicating dynamic trafficking of vesicles between the Golgi and reservosomes. Our immunolocalization analyzes did not reveal any TcHIP labeling in reservosomes. It has been shown that each epimastigote form contains only a few reservosomes, all at their posterior end (Soares and De Souza, 1988) . It is possible that TcHIP would be enriched and detectable in a purified reservosomal fraction, but is present at non-detectable levels in reservosomes of intact cells processed for immunolocalization studies. It is also possible that the detection of TcHIP in this purified reservosomal fraction may have been due to contamination. Further studies are required to characterize the importance of TcHIP in the cell biology of T. cruzi.
